PMID: 6990478Jan 1, 1980Paper

Stones in renal transplants

Scandinavian Journal of Urology and Nephrology
E NormannS Halvorsen

Abstract

In a 50-year-old man (case 1) and a 17-year-old girl (case 2) stones developed in a functioning renal transplant. The respective intervals from transplantation to appearance of stone were seven years and six months. The serum calcium was elevated to approximately 3.00 mmol/l in case 1 and 2.65 mmol/l in case 2. The concentration of parathyroid hormone in serum was increased in case 1. Subtotal parathyroidectomy was performed in both patients, with removal of 2550 mg (case 1) and 150-160 mg (case 2) parathyroid tissue. In case 2 slight hypercalcaemia reappeared two months later. When stones in a transplanted kidney are associated with only slight hypercalcaemia and there is no deterioration of the renal function, conservative measures to reduce the serum calcium should be tried before subtotal parathyroidectomy is undertaken.

References

Jan 1, 1977·Acta Medica Scandinavica·M S ChristensenS Torring
May 1, 1977·The Journal of Urology·R T SchweizerB B Berlin
Aug 1, 1978·British Journal of Urology·B S Lucas, J E Castro
Aug 1, 1978·Kidney International·S O Thier
Jul 1, 1976·American Journal of Surgery·S T BigosW T Goar
Mar 11, 1975·American Journal of Surgery·J C RosenbergA J Walt
Aug 23, 1973·The New England Journal of Medicine·D S DavidL M Sherwood
Sep 1, 1970·The American Journal of Medicine·J M DominguezM E Molins

❮ Previous
Next ❯

Citations

Nov 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B HessP Jaeger
Sep 1, 1991·Urology·J Miñon CifuentesC Alferez
Dec 1, 1988·The Journal of Urology·T C Caldwell, J R Burns
Oct 10, 2001·The Korean Journal of Internal Medicine·H KimH W Ham
Sep 1, 1984·The Journal of Urology·G G MotayneR P Abele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.